VTv Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, sales was USD 2.01 million compared to USD 4 million a year ago. Net loss was USD 14.42 million compared to USD 5.94 million a year ago. Basic loss per share from continuing operations was USD 0.2 compared to USD 0.1 a year ago.